Skip to main content
Oncogenesis logoLink to Oncogenesis
. 2022 Nov 18;11(1):68. doi: 10.1038/s41389-022-00442-2

Correction: Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells

L Jiang 1,#, J Zhou 2,#, D Zhong 3,#, Y Zhou 3, W Zhang 4, W Wu 5, Z Zhao 3, W Wang 3, W Xu 3, L He 3, Y Ma 3, Y Hu 3, W Zhang 3,, J Li 6
PMCID: PMC9674687  PMID: 36400761

Correction to: Oncogenesis 10.1038/oncsis.2017.8, published online 13 March 2017

Following the publication of this article the authors noted that an incorrect image had been presented in Fig. 5c. The correct lower image of intracranial brain tumor of SW1088/Vector control mice is provided below. This correction has no effect on the conclusions of the article.

Fig. 5. SMC4 accelerates glioma cell tumorigenicity in vivo.

Fig. 5

c Intracranial brain tumor xenograft model in nude mice; representative images of tumors from each group are shown. Hematoxylin–eosin (H&E, lower panel magnification, × 100) staining demonstrated that SMC4 overexpression induced the aggressive phenotype of glioma cells in vivo, whereas SMC4 suppression inhibited it.


Articles from Oncogenesis are provided here courtesy of Nature Publishing Group

RESOURCES